Get notified when TWAV files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTaoWeave raises capital via SAFE and debt financing, enters tech partnership with Manako Labs
Filed June 3, 2026 · Period ending May 28, 2026 · ~1 min read
Key Changes
-
high
TaoWeave secured financing through a SAFE (converts to equity later) and TLDA (debt) from Manako Labs, announced June 1. Specific amounts not disclosed, but represents immediate capital infusion with future dilution risk.
Item 7.01, 9.01 verify on EDGAR → -
high
Company signed technology license and distribution agreement with Manako Labs on May 28. Key terms redacted, but suggests commercial partnership for TaoWeave's technology with potential revenue implications.
Item 9.01 - Exhibit 10.1 view on EDGAR → -
medium
TaoWeave issued warrants to Manako Labs as part of financing package. Warrants allow future share purchases at set price, creating potential dilution when exercised but common in startup financing.
Item 3.02, Exhibit 4.1 view on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.
Partner
Trade TWAV commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify